These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6994777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term treatment of hypertension with guanfacine alone and in combination therapy.
    Seedat YK.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):65S-66S. PubMed ID: 6994781
    [No Abstract] [Full Text] [Related]

  • 3. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
    Jerie P.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M, Overlack A, Stumpe KO.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC, Rassi S, Lopes M, Simioni PR, Guimarães E, Maranhão MF, Porto CC.
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract] [Full Text] [Related]

  • 9. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M.
    Neth J Med; 1987 Aug 04; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 04; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 15. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R, Reda G, Spallone L, Anguissola AB.
    Br J Clin Pharmacol; 1980 Mar 04; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term clinical experience with guanfacine.
    Fetkovská N, Brimichová G, Sebeková K, Dzúrik R.
    Cor Vasa; 1987 Mar 04; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.